Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center

Surgical Infections

Volumn 12, Issue 2, 2011, Pages 105-111

  Salvador, Vincent Bryan D G ^a   Lozada, Maria Cristina H ^a   Consunji, Rafael J ^a  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; GENTAMICIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ALCALIGENES FAECALIS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURKHOLDERIA MALLEI; CANDIDA; CHILD; CHOLANGITIS; CITROBACTER; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; HAFNIA ALVEI; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PANTOEA AGGLOMERANS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROVIDENCIA RETTGERI; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS GROUP D; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BILE; CHILD; CHILD, PRESCHOOL; CHOLANGITIS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHILIPPINES; YOUNG ADULT;

EID: 79955787147     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2010.005     Document Type: Article

References (23)

1. Miho S, Tadahiro T, Yoshifumi K, et al. Need for criteria for the diagnosis and severity assessment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreatic Surg 2007;14:11-14.
2. Fumihiko M, Tadahiro T, Yoshifumi K, et al. Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007;14:27-34.
3. van den Hazel SJ, Speelman P, Tytgat GN, et al. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis 1994;19:279-286. (Pubitemid 24258927)
4. Russo M, Carmellino S, Russo G. Bacterial cholangitis: Therapeutic features. Infez Med 1999;7:142-155.
5. Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin North Am 1990;70:1297-1312.
6. Sung JJ, Lyon DJ, Suen R, et al. Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis: A randomized, controlled clinical trial. J Antimicrob Chemother 1995;35:855-864.
7. Ratanachu-ek T, Prajanphanit P, Leelawat K, et al. Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2007;13:276-279. (Pubitemid 46231332)
8. Sheen-Chen S, Chen W, Eng H, et al. Bacteriology and antimicrobial choice in hepatolithiasis. Am J Infect Control 2000;28:298-310.
9. Tanaka A, Takada T, Kawarada Y et al. Antimicrobial therapy for acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007;14:59-67. (Pubitemid 46189143)
10. Westphal JF, Brogard JM. Biliary tract infections: A guide to drug treatment. Drugs 1999;57:81-91.
11. Qureshi, WA. Approach to the patient who has suspected acute bacterial cholangitis. Gastroenterol Clin N Am 2006;35: 409-423. (Pubitemid 44137418)
12. Keita W, Tadahiro T, Yoshifumi K, et al. Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg 2007;14:52-58.
13. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infections in adults and children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect 2010;11:79-109.
14. Hsueh P, Snyder T, DiNubile M, et al. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 Results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 2006;28:238-243. (Pubitemid 44223984)
15. Hawser SP, Bouchillon SK, Hoban DJ, Badal RE. Epidemiologic trends, occurrence of extended-spectrum betalactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: Analysis of global trend data from 2002-2007 from the SMART study. Surg Infect 2010;11:371-378.
16. Boey JH, Way LW. Acute cholangitis. Ann Surg 1980; 191:264-270. (Pubitemid 10184237)
17. Saik R, Greenburg AG, Farris J, et al. Spectrum of cholangitis. Am J Surg 1975;130:143-148.
18. Neve R, Biswas S, Dhir V, et al. Bile cultures and sensitivity patterns in malignant obstructive jaundice. Indian J Gastroenterol 2003;22:16-18. (Pubitemid 36262279)
19. Chang WT, Lee KT, Wang SR, et al. Bacteriology and antimicrobial susceptibility in biliary tract disease: An audit of 10-years' experience. Kaohsiung J Med Sci 2002;18:221-228.
20. Flores C, Maguilnik I, Hadlich E, et al. Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. J Gastroenterol Hepatol 2003;18: 333-336. (Pubitemid 36513164)
21. Pitt HA, Postier RG, Cameron JL. Biliary bacteria: Significance and alterations after antibiotic therapy. Arch Surg April 1982;117:445-449. (Pubitemid 12084967)
22. Paterson DL, Bonomo RA. Extended-spectrum beta lactamases: A clinical update. Clin Microbiol Rev 2005;18:657-686. (Pubitemid 41504510)
23. Sharma S, Kumar A. Antimicrobial management of sepsis and septic shock. Clin Chest Med 2008;29:677-687.